AC
ADMA icon

AXQ Capital’s ADMA Biologics ADMA Stock Holding History

AXQ Capital’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$444K Sell
53,105
-8,684
-14% -$79.2K 0.05% 515
2026
Q1 		$557K Buy
61,789
+42,148
+215% +$665K 0.07% 385
2025
Q4 		$358K Sell
19,641
-78
-0.4% -$1.31K 0.08% 380
2025
Q3 		$289K Buy
+19,719
New +$338K 0.11% 326
2024
Q2 		– Sell
-19,800
Closed -$131K – 431
2024
Q1 		$131K Buy
+19,800
New +$108K 0.03% 561

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AXQ Capital's ADMA Position: Q2 2026 in Review

AXQ Capital reduced its ADMA Biologics (ADMA) stake by 14% in Q2 2026, selling an estimated $79.2K and leaving 53,105 shares worth $444K. The position accounts for 0.05% of the portfolio, ranked #515.

AXQ Capital first reported a position in ADMA in Q1 2024 and has held it in 5 quarters since. The position peaked at $557K in Q1 2026. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • AXQ Capital held 53,105 shares of ADMA Biologics worth $444K as of Q2 2026.
  • AXQ Capital sold 8,684 ADMA Biologics shares in Q2 2026, an estimated $79.2K.
  • ADMA Biologics made up 0.05% of AXQ Capital's portfolio in Q2 2026, its #515 holding.
  • AXQ Capital first reported a position in ADMA Biologics in Q1 2024 and has held it in 5 quarters since.
  • AXQ Capital's ADMA Biologics position peaked at $557K in Q1 2026.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.